ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2022

Interpretable Machine Learning Models to Predict the Resistance of Breast Cancer Patients to Doxorubicin from Their microRNA Profiles.

Adeolu Z Ogunleye et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.